Suppression of haematopoiesis during therapy of chronic hepatitis C with different interferon α mono and combination therapy regimens

od Schmid, M, Kreil, A, Jessner, W, Homoncik, M, Datz, C, Gangl, A, Ferenci, P, Peck-Radosavljevic, M
Wydane 2005

A multicentre, open-label, phase-I/randomised phase-II study to evaluate safety, pharmacokinetics, and efficacy of nintedanib vs. sorafenib in European patients with advanced hepat...

od Palmer, D. H., Ma, Y. T., Peck-Radosavljevic, M., Ross, P., Graham, J., Fartoux, L., Deptala, A., Studeny, M., Schnell, D., Hocke, J., Loembé, A-B., Meyer, T.
Wydane w Br J Cancer (2018)

Impact of patatin‐like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension

od Mandorfer, M., Scheiner, B., Stättermayer, A. F., Schwabl, P., Paternostro, R., Bauer, D., Schaefer, B., Zoller, H., Peck‐Radosavljevic, M., Trauner, M., Reiberger, T., Ferenci, P., Ferlitsch, A.
Wydane w Aliment Pharmacol Ther (2018)

Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt

od Angermayr, B, Cejna, M, Karnel, F, Gschwantler, M, Koenig, F, Pidlich, J, Mendel, H, Pichler, L, Wichlas, M, Kreil, A, Schmid, M, Ferlitsch, A, Lipinski, E, Brunner, H, Lammer, J, Ferenci, P, Gangl, A, Peck-Radosavljevic, M
Wydane 2003